XML 34 R24.htm IDEA: XBRL DOCUMENT v3.22.2.2
Net Loss Per Share
9 Months Ended
Sep. 30, 2022
Earnings Per Share [Abstract]  
Net Loss Per Share

(17) Net Loss Per Share

The unaudited basic and diluted net loss per share for the three and nine months ended September 30, 2021 has been computed to give effect to the conversion of shares of Legacy Quanergy convertible preferred stock into shares of Legacy Quanergy common stock as though the conversion had occurred as of the beginning of the period. Shares of the Company’s common stock reflect the reverse stock split and the Exchange Ratio as though the conversion had occurred as of the beginning of the period.

The following table sets forth the computation of the basic and diluted net loss per share attributable to common stockholders for the three and nine months ended September 30, 2022 and 2021, respectively (in thousands, except share and per share data):

 

 

 

Three Months Ended September 30,

 

 

Nine Months Ended September 30,

 

 

 

2022

 

 

2021

 

 

2022

 

 

2021

 

Numerator:

 

 

 

 

 

 

 

 

 

 

 

 

Net loss attributable to common stockholder, basic and diluted

 

$

(17,652

)

 

$

(18,999

)

 

$

(148,008

)

 

$

(54,180

)

Denominator:

 

 

 

 

 

 

 

 

 

 

 

 

Weighted average shares of common stock outstanding, basic and diluted

 

 

6,824,212

 

 

 

3,463,403

 

 

 

5,793,554

 

 

 

3,320,498

 

Net loss per share attributable to common stockholder, basic and diluted

 

$

(2.59

)

 

$

(5.49

)

 

$

(25.55

)

 

$

(16.32

)

Since the Company was in a loss position for all periods presented, basic net loss per share is the same as diluted net loss per share for all periods as the inclusion of all potential common shares outstanding would be anti-dilutive.

The following table presents the potential common shares outstanding that were excluded from the computation of diluted net loss per share of common stock as of the periods presented because including them would be anti-dilutive:

 

 

 

As of September 30,

 

 

 

2022

 

 

2021

 

Public warrants

 

 

689,999

 

 

 

 

Private placement warrants

 

 

376,000

 

 

 

 

GEM warrants

 

 

169,896

 

 

 

 

Stock options and RSUs issued and outstanding

 

 

676,643

 

 

 

719,502

 

Convertible notes

 

 

 

 

 

196,733

 

Potential common shares excluded from diluted net loss per share

 

 

1,912,538

 

 

 

916,235